Home
/
Monopar Therapeutics
/
Financials
/
Quarterly
Monopar Therapeutics — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Monopar Therapeutics filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$0
Nov 13, 2025
Q2
2025
Jun 30, 2025
$0
Aug 12, 2025
Q1
2025
Mar 31, 2025
$0
May 13, 2025
Q3
2019
Sep 30, 2019
$0
Nov 12, 2019
Q2
2019
Jun 30, 2019
$0
Aug 8, 2019
Q1
2019
Mar 31, 2019
$0
May 10, 2019
Q3
2018
Sep 30, 2018
$0
Nov 9, 2018
Q2
2019
Jun 30, 2018
$0
Aug 8, 2019
Q3
2019
Jun 30, 2018
$0
Nov 12, 2019
Q1
2019
Mar 31, 2018
$0
May 10, 2019
Q3
2018
Sep 30, 2017
$0
Nov 9, 2018
Q2
2018
Jun 30, 2017
$0
Aug 9, 2018
Q1
2018
Mar 31, 2017
$0
May 11, 2018
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.44M)
Nov 13, 2025
Q3
2025
Jun 30, 2025
($2.45M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($2.45M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($2.62M)
May 13, 2025
Q2
2025
Mar 31, 2025
($2.62M)
Aug 12, 2025
Q3
2025
Mar 31, 2025
($2.62M)
Nov 13, 2025
Q3
2025
Sep 30, 2024
($1.30M)
Nov 13, 2025
Q3
2025
Jun 30, 2024
($1.72M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($1.72M)
Aug 12, 2025
Q3
2025
Mar 31, 2024
($1.64M)
Nov 13, 2025
Q1
2025
Mar 31, 2024
($1.64M)
May 13, 2025
Q2
2025
Mar 31, 2024
($1.64M)
Aug 12, 2025
Q3
2024
Sep 30, 2023
($1.95M)
Nov 8, 2024
Q3
2024
Jun 30, 2023
($2.20M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($2.20M)
Aug 9, 2024
Q3
2024
Mar 31, 2023
($2.43M)
Nov 8, 2024
Q1
2024
Mar 31, 2023
($2.43M)
May 9, 2024
Q2
2024
Mar 31, 2023
($2.43M)
Aug 9, 2024
Q3
2023
Sep 30, 2022
($2.40M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($2.76M)
Aug 10, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($4.09M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($3.23M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($3.22M)
May 13, 2025
Q3
2025
Sep 30, 2024
($1.57M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($1.79M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($1.72M)
May 13, 2025
Q3
2024
Sep 30, 2023
($2.07M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($2.33M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($2.53M)
May 9, 2024
Q3
2023
Sep 30, 2022
($2.41M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($2.76M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($2.46M)
May 11, 2023
Q3
2022
Sep 30, 2021
($2.46M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($2.09M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($1.89M)
May 12, 2022
Q3
2021
Sep 30, 2020
($1.65M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($1.46M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($1.14M)
May 13, 2021
Q3
2020
Sep 30, 2019
($759.4K)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($932.1K)
Aug 6, 2020